¥4.50   ( %)
前日收盘: 当日成交量(股): 当日最高: 总股本:3202.58万
当日开盘: 当日成交额(元): 当日最低: 流通股本:
市盈率(动/静):0/0 市净率:0 市销率:0 总市值:1.44亿
52周最高:10.44 52周最低:4.20 转让方式: 单位:美元
$ASLAN Pharmaceuticals(ASLN)$
  • 还可以输入
  • 20016

ASLAN Pharmaceuticals(ASLN) 12月07日 02时14分

查看全文

ASLAN Pharmaceuticals(ASLN) 12月03日 01时08分

新闻 New Data on ASLAN003 Presented at Ash Annual Meeting Shows First Signs of Clinical Activity of a DHODH Inhibitor in Acute Myeloid Leukaemia SINGAPORE, Dec. 03, 2018 (GL ......  url.vc.watch/nHnx
查看全文

ASLAN Pharmaceuticals(ASLN) 11月29日 02时54分

新闻 ASLAN Pharmaceuticals Announces Acceptance of Abstracts on New Varlitinib Data in BTC at ASCO Gastrointestinal Cancers Symposium SINGAPORE, Nov. 27, 2018 (GLOBE NEWSWIR ......  url.vc.watch/nUPu
查看全文

ASLAN Pharmaceuticals(ASLN) 11月21日 00时39分

新闻 Aslan Pharmaceuticals to Participate in 30th Annual Piper Jaffray Healthcare Conference
SINGAPORE, Nov. 20, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, ......  url.vc.watch/nwO5
查看全文

ASLAN Pharmaceuticals(ASLN) 11月09日 01时19分

新闻 ASLAN Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
SINGAPORE, Nov. 08, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NAS ......  url.vc.watch/nlFV
查看全文

ASLAN Pharmaceuticals(ASLN) 11月01日 23时49分

新闻 ASLAN Pharmaceuticals to Present New Data on ASLAN003 at American Society of Hematology Annual Meeting SINGAPORE, Nov. 01, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceutical ......  url.vc.watch/JYdC
查看全文

ASLAN Pharmaceuticals(ASLN) 10月31日 18时40分

查看全文

ASLAN Pharmaceuticals(ASLN) 10月30日 17时12分

新闻 ASLAN Pharmaceuticals Appoints Robert E. Hoffman as Independent Director
SINGAPORE, Oct. 30, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a ......  url.vc.watch/JQma
查看全文

ASLAN Pharmaceuticals(ASLN) 10月25日 23时07分

新闻 New Data Presented on ASLAN’s varlitinib at ESMO Show Promising Results in Heavily Pre-Treated BTC and CRC Patients New Data Presented on ASLAN's varlitinib at ESMO Show ......  url.vc.watch/JyrE
查看全文

ASLAN Pharmaceuticals(ASLN) 10月18日 01时23分

新闻 ASLAN Pharmaceuticals Enrolls First Subject in Phase 1 Study for ASLAN004 in Atopic Dermatitis
SINGAPORE, Oct. 18, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (ASLAN ......  url.vc.watch/JrTZ
查看全文

ASLAN Pharmaceuticals(ASLN) 10月09日 22时50分

新闻 ASLAN Pharmaceuticals to Present Posters on Varlitinib and ASLAN003 at European Society for Medical Oncology Congress SINGAPORE, Oct. 09, 2018 (GLOBE NEWSWIRE) -- ASLAN ......  url.vc.watch/JIu4
查看全文

ASLAN Pharmaceuticals(ASLN) 09月22日 00时21分

新闻 ASLAN Pharmaceuticals Presents Two Posters on Varlitinib at Chinese Society of Clinical Oncology Annual Meeting SINGAPORE, Sept. 21, 2018 (GLOBE NEWSWIRE) -- ASLAN Phar ......  url.vc.watch/JLU5
查看全文

ASLAN Pharmaceuticals(ASLN) 09月18日 01时30分

新闻 ASLAN Pharmaceuticals Provides Update on Timelines for Clinical Trial of Varlitinib in Biliary Tract Cancer in China Management will host a conference call and webcast to ......  url.vc.watch/JGcP
查看全文

ASLAN Pharmaceuticals(ASLN) 09月04日 16时06分

新闻 ASLAN Pharmaceuticals to Present at HC Wainwright 20th Annual Global Investment Conference
SINGAPORE, Sept. 04, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:A ......  url.vc.watch/jkQ0
查看全文

ASLAN Pharmaceuticals(ASLN) 08月20日 15时19分

新闻 ASLAN Pharmaceuticals Granted Orphan Drug Designation by the FDA for ASLAN003 for the Treatment of Acute Myeloid Leukaemia SINGAPORE, Aug. 20, 2018 (GLOBE NEWSWIRE) -- ......  url.vc.watch/jDcO
查看全文

ASLAN Pharmaceuticals(ASLN) 08月16日 05时41分

新闻 ASLAN Pharmaceuticals Submits Clinical Trial Authorisation Application for First in Man Studies for ASLAN004 SINGAPORE, July 03, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmace ......  url.vc.watch/jpJ3
查看全文

ASLAN Pharmaceuticals(ASLN) 08月16日 05时41分

新闻 ASLAN Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update
SINGAPORE, Aug. 06, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NA ......  url.vc.watch/jpJt
查看全文

ASLAN Pharmaceuticals(ASLN) 08月16日 05时41分

新闻 ASLAN Pharmaceuticals Completes Recruitment for Global Phase 2 Study for Varlitinib in First Line Gastric Cancer SINGAPORE, Aug. 10, 2018 (GLOBE NEWSWIRE) -- ASLAN Phar ......  url.vc.watch/jpJR
查看全文

ASLAN Pharmaceuticals(ASLN) 06月05日 02时11分

查看全文

ASLAN Pharmaceuticals(ASLN) 06月05日 02时11分

查看全文
  • 首页 上一页 1 2 3 下一页 尾页  每页20条/共45